The study drug is a potential new treatment for epilepsy, in particular epilepsy does not respond well to existing anti-epilepsy treatments.
There are currently various treatments available for epilepsy, but there are still patients who seizures are not well-controlled with the current treatments. It is hoped that this study drug would be a more effective treatment for those patients.
This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.
Call us on 1800 243 733 to discuss your eligibility today!